![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
01 GILEAD SCIENCES INT.LTD (2)
01 Emtricitabine; Tenofovir Disoproxil; elvitegravir; Cobicistat (2)
01 Italy (2)
01 Emtricitabine+Tenofovir+Elvitegravir+Cobicistat 200Mg+245+150Mg Mg+150Mg 30 Joined' Oral Use (1)
02 Emtricitabine+Tenofovir+Elvitegravir+Cobicistat 200Mg+245Mg+150+150Mg 90 Mg Unit Oral Use (1)